|
Fig. 1. The stage 46 Xenopus tadpole gut.
(A) Schematic diagram (ventral view/anterior
at the top). (B) Whole-mount drawing
(ventral and lateral views). The gut has been
shaded dark grey and the liver and pancreas
light grey. oe, oesophagus; lv, liver; gb, gall
bladder; pa, pancreas; sia, proximal small
intestine; sib, external coil of small intestine;
sic, internal coil of small intestine; lic,
internal coil of large intestine; lid, distal large
intestine; st, stomach; pr, proctodaeum; ht,
heart. Figure adapted from Chalmers and
Slack (1998), with permission. Bar, 1 mm.
|
|
Fig. 2. The 14 regions used for fate mapping. (A) Left view of a
stage 14 whole mount. (B) Dorsal view of a stage 14 whole mount.
(C) Parasagittal section of a stage 14 embryo. (D) Transverse section
of a stage 14 embryo. The grafting regions are shown on the embryos
using the following labels: 1, extreme anterior; 2, anterior dorsal; 3,
anterior right; 4, anterior left; 5, anterior ventral; 6, middle dorsal; 7,
middle right; 8, middle left; 9, middle ventral; 10, posterior dorsal;
11, posterior right; 12, posterior left, 13; posterior ventral; 14
extreme posterior.
|
|
Fig. 3. Examples of FDA labelling. For each example a labelled drawing of a section (A,C,E,G,I) and a photograph of the labelled section
(B,D,F,H,J) are shown. A whole-mount drawing is also included at the top of the figure to show the position of the sections in the tadpole.
(A,B) Labelled pharynx. (C,D) Labelled pancreas and small intestine. (E,F) Labelled small intestine. (G,H) Labelled proctodaeum.
(I,J) Labelled smooth muscle in the large intestine. (K) Smooth muscle layer in the tadpole gut. In B,D,F,H and J, arrowheads highlight labelled
epithelia and arrows highlight smooth muscle. ph, pharynx; tn, tongue; sia, proximal small intestine; pa, pancreas; st, stomach; lid, distal large
intestine; pr, proctodaeum. Bar, 200 mm (B); 120 mm (F,H); 95 mm (D,J); 30 mm (K).
|
|
Fig. 4. Representative examples of the fate
mapping. Drawings of sections from
representative examples of eight of the 14
regions are shown. The position of the FDA
label has been added to the drawings (green).
A whole-mount drawing and drawings of
standard sections are also shown to aid
interpretation of the labelled sections (adapted
from Chalmers and Slack, 1998). ph, pharynx;
tn, tongue; ov, otic vesicle; no, notochord; ht,
heart; lv, liver; tr, trachea; sia, proximal small
intestine; sib, external coil of small intestine;
sic, internal coil of small intestine; lic, internal
coil of large intestine; lid, distal large
intestine; pa, pancreas; bd, bile duct; lu, lungs;
nd, nephritic ducts; pr, proctodaeum.
|
|
Fig. 5. The endoderm and smooth
muscle layer fate maps. (A) The
endoderm fate map. The organ rudiments
of the extreme anterior (1) (yellow),
anterior dorsal (2) and ventral (5) (red),
middle dorsal (6) and ventral (9) (blue),
posterior dorsal (10) and ventral (13)
(green) and extreme posterior (14)
(black) endoderm are labelled at the
position they form on a drawing of a
stage 14 embryo. For the sake of clarity
the lateral rudiments have not been
included. (B) Projection of the early
ventral endoderm onto the tadpole gut.
The extreme anterior (1) (yellow),
anterior ventral (5) (red), middle ventral
(9) (blue), posterior ventral (13) (green)
and extreme posterior regions (14)
(black) are shaded in the embryo and in
the regions they will give rise to in the
tadpole gut. The drawings are viewed
from the ventral side with anterior at the
top. (C) Projection of the early dorsal
endoderm. As in B but for the dorsal
rather than ventral regions. (D) Location
of the dorsal, lateral and ventral digestive
tract rudiments for comparison with the
smooth muscle layer fate map. The
lateral rudiments are shown in the
middle of the dorsal/ventral axis to
represent their position on the side of the
embryo. (E) Smooth muscle layer fate
map. The position in the mesoderm of
the lateral and ventral rudiments for the
smooth muscle layer of the gut is shown
on a drawing of a stage 14 embryo. None
of the dorsal regions were fated to form
smooth muscle. (F) Presumptive gene
expression domains in the dorsal and
ventral Xenopus endoderm. Regions of
the endoderm that will give rise to
tissues that express Xlhbox8 or IFABP in
normal development are highlighted with
coloured diagonal lines. ph, pharynx; tn, tongue; tr, trachea; lu, lungs; lv, liver; gb, gall bladder; pa, pancreas; bd, bile duct; oe, oesophagus; st,
stomach; si, small intestine; sia, proximal small intestine; sib, external coil of small intestine; sic, internal coil of small intestine; li, large
intestine; lic, internal coil of large intestine; lid, distal large intestine; pr, proctodaeum.
|
|
Fig. 6. DiI labelling of the Xenopus endoderm.
(A) Section of control stage 14 embryo. The four
labelling positions are marked with arrows. (B) Section
of control stage 40 embryo. (C) Whole-mount stage 45
control gut. (D) Section of floor DiI labelling at stage 14
(the archenteron is shrunk because of the replacement of
the roof). Insert shows high magnification view.
(E) Section of floor DiI labelling visualised at stage 39.
(F) Floor DiI labelling visualised in a stage 45 whole
mount. (G) Section of middle labelling at stage 14.
(H) Section of middle DiI labelling visualised at stage 39.
(I) Middle DiI labelling visualised in a stage 45 whole
mount. (J) Section of ventral DiI labelling at stage 14.
(K) Section of ventral DiI labelling visualised at stage 39.
(L) Ventral DiI labelling visualised in a stage 45 whole
mount. (M) Section of dorsal DiI labelling at stage 14.
Insert shows high magnification view. (N) Section of
dorsal DiI labelling visualised at stage 39. (O) Dorsal DiI
labelling visualised in a stage 45 whole mount. Arrows
highlight DiI label. no, notochord; ar-r, archenteron roof;
ar-f, archenteron floor.
|
|
Fig. 7. DiI/FDA double labelling of the
Xenopus endoderm. (A) Section of stage 14
control embryo. The four labelling positions
are marked with arrows. (B) Floor DiI and
ventral FDA double labelling visualised in a
stage 45 whole mount. (C) Floor DiI and
dorsal FDA double labelling visualised in a
stage 45 whole mount. (D) Middle DiI and
ventral FDA double labelling visualised in a
stage 45 whole mount.
|
|
Fig. 8. The archenteron
cavity during development.
The superficial cell layer that
gives rise to the cells lining
the archenteron was labelled
at stage 9/10. The labelled
cells lining the archenteron
could then be followed
during development.
(A) Unlabelled stage 14
embryo. (B) Biotin-labelled
cells at stage 14 (arrow).
(C) Unlabelled stage 38
embryo showing
endogenous signal in the
epidermis but not the gut.
(D,E) Biotin-labelled cells
(arrow) at stage 38 showing
partial closure of
archenteron. (F) Biotinlabelled
cells (arrow) at
stage 40 showing small
persistent archenteron. The
label is lost from the internalised cells. (G) Biotin-labelled cells in the posterior gut of a stage 40 embryo showing new cavity opening (arrow,
biotin; arrowhead, unlabelled). (H) Biotin-labelled cells in the posterior gut at stage 42 showing cavity is only partially labelled (arrow, biotin;
arrowhead, unlabelled). (I) Biotin-labelled cells (arrow) in stage 44 gut showing partial labelling of new cavity. Bar, 100 mm; 50 mm (E,G-I).
|
|
Fig. 9. Morphogenesis of the gut epithelium. From stage 14 to stage
38 the embryonic archenteron narrows to a small cavity. During this
time the dorsal (red), floor (blue), middle (black) and ventral (green)
cell populations retain their relative positions. After stage 38 the gut
cavity starts to open from the remains of the archenteron to split the
ventral endoderm. This produces a cavity, part of which originated
from the archenteron (solid line) and part is the new cavity (dashed
line). By stage 45 the gut cavity is fully open. The splitting of the
ventral endoderm places the cells of the archenteron (red + blue) on
one side of the cavity and the middle (black) and ventral endoderm
cells (green) on the other side. Radial intercalation may drive both
the opening of the gut cavity and the elongation of the gut.
|